AECOMACM
Price$58.95Intrinsic value$79.8235% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $15.4B-4.4% YoYTTM through 30 Jun 2026
Net Income $288M-28.4% YoYTTM through 30 Jun 2026
Free Cash Flow $203.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin7.8%
EBITDA Margin4.6%
Operating Margin6.5%
Net Margin1.9%

Returns

13.1%ROE
2.4%ROA
7.5%ROIC

Balance Sheet Health

Debt / Equity1.21x
Current Ratio1.06x
Net Debt$1.7B
Cash & Equivalents$1B

Quality Metrics

Altman Z-Score1.80
Piotroski F-Score4 / 9
FCF Margin1.3%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $16.1B
Diluted EPS$2.19TTM
'19'20'21'22'23'24'25
FY2025: $4.21

Dividend

$0.93Per share, FY20261.49%Yield

Capital Allocation

Capex Intensity1.1%

Segment Performance

SegmentRevenueYoYOutlook
Americas
International

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.